about
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studiesRespiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review.Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank.Triggers of spontaneous preterm delivery--why today?Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studiesElevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?Use of topiramate in pregnancy and risk of oral clefts.Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer.Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort.Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results.Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple Sclerosis.Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias.Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States.Ophthalmic nepafenac use in the Netherlands and Denmark.Effects of gestational age at enrollment in pregnancy exposure registries.Risk Factors for RSV Hospitalization in Healthy Preterm Infants: A Meta-analysis.Reply to Journal Club Roundtable.Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink.Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom.Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study.The Safety of Medications in Pregnant Women: An Opportunity to Use Database Studies.Variation in cardiovascular risk related to individual antimuscarinic drugs used to treat overactive bladder. A cohort study in the UK.Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United KingdomUse of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRDRelation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth
P50
Q26999933-29FE0636-FB19-4E4B-ACBA-69D3B9009D23Q30251560-481C5690-B538-43E6-95B8-AC4B037CA905Q33456912-A78F5A75-9206-41E8-A248-B55E36C11F71Q33932741-6A2C47B7-07EC-4B1E-B257-6A5306FE67FEQ35894680-7E2201E0-7126-4489-BE9E-402894B2E3DCQ35963098-798671DC-5C41-4BFB-B855-044F87C3562AQ36356810-C0563F8A-4CED-4CC4-8EA6-D8DBDE70A0A4Q36468237-C53DC7C0-145A-454D-8D1F-51E8C75F1FA0Q37455795-29503569-8DD4-448D-A094-84D54B73C4E8Q37558365-5CD32CD3-C2AD-457C-9E8A-6E8EACCA7667Q38174445-80E9496D-D4D6-40C6-A41E-250EBD802EE6Q38334947-F585D28A-B78C-4F76-83FF-F067A568E6CAQ38653267-CC788901-185B-4344-B0E5-2176DCCA5788Q38859664-207A294D-263E-4D2F-9F1E-7800EE764C42Q40060039-A916E03E-9C0C-4BD6-A297-33689E7C62E7Q41066233-73AD1F5D-8719-44BB-A284-DED865B45787Q41375979-A6AA75A6-745E-4E71-B2D0-F7C2C70470AEQ42202888-44194B86-F4E1-4678-B8A0-58CDCC1F0F42Q44418846-3AEA8B5E-CA2D-4F1A-B76D-683542F34593Q46142866-6549DBEB-FD7F-4BD1-B87A-C13A900D77D9Q47601113-7C2B7176-9FD0-4AFC-AA9B-B2263765CD22Q47603300-DB3CF6BA-D2FF-41BD-A057-3ADCD0B117A0Q50516045-B2DC79D9-8ECE-4DD3-84DB-9EE23278B677Q53820501-B8200423-7754-4B5E-AB63-586AB5F88FEEQ57608703-D1F8B107-1FF9-488F-9F97-45B1E00D7EC8Q86893161-B912F92B-7ED7-4791-B881-1A413A7488D1Q92416787-B61EC7E2-B9D9-450C-9C30-C731224EA2CB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andrea V Margulis
@ast
Andrea V Margulis
@en
Andrea V Margulis
@es
Andrea V Margulis
@nl
type
label
Andrea V Margulis
@ast
Andrea V Margulis
@en
Andrea V Margulis
@es
Andrea V Margulis
@nl
prefLabel
Andrea V Margulis
@ast
Andrea V Margulis
@en
Andrea V Margulis
@es
Andrea V Margulis
@nl
P1053
G-2833-2013
P106
P31
P3829
P496
0000-0001-7388-6082